CNRClinical Neuroscience Research3083-48992981-8133Bio-Byword Scientific Publishing Pty. Ltd.10.26689/cnr.v3i4.13510ArticleResearch on Alzheimer’s Disease Assisted Diagnosis Model Based on Deep Machine Learning for Corpus Cavernosum Segmentation and Plasma Biomarkershttps://artdesignp.com/journal/CNR/3/4/10.26689/cnr.v3i4.13510YuanWenjie,YuXiang2025342025-12-31Early diagnosis of Alzheimer’s disease (AD) is key to improving prognosis, but existing methods have limitations. This article reviews the research on AD-assisted diagnosis based on deep learning sponge segmentation and plasma biomarker fusion. Firstly, elucidate the pathological mechanism and clinical characteristics of AD, and clarify the core value of the corpus cavernosum as an imaging biomarker and plasma biomarkers (such as A β and p-tau) as molecular markers. Next, analyze the technical foundation of deep learning in medical image segmentation and summarize its application progress in sponge segmentation. MRI is the main modality, and after preprocessing, models such as U-Net variants can achieve high-precision segmentation (Dice coefficient exceeding 0.85). At the same time, the application of deep learning in plasma biomarker screening, AD diagnosis, and other scenarios was reviewed, and the model AUC can reach 0.85~0.92. Multimodal fusion achieves macroscopic and microscopic pathological complementarity by integrating imaging and plasma data, significantly improving diagnostic efficiency. However, it faces challenges such as data heterogeneity, insufficient sample matching, and poor model interpretability. Finally, it is pointed out that the future needs to focus on the construction of standardized datasets, the development of lightweight fusion models, and clinical translation, in order to provide technical support for accurate diagnosis of AD.

Liu S, Masurkar A, Rusinek H, et al., 2022, Generalizable Deep Learning Model for Early Alzheimer’s Disease Detection from Structural MRIs. Scientific Reports, 12(1): 17106.

Zhu Q, Xu B, Huang J, et al., 2023, Deep Multi-Modal Discriminative and Interpretability Network for Alzheimer’s Disease Diagnosis. IEEE Transactions on Medical Imaging, 42(5): 1342–1353.

Odusamig F, Maskeliūnas R, Damaševičius R, et al., 2023, Explainable Deep Learning Based Diagnosis of Alzheimer’s Disease Using Multimodal Input Fusion of PET and MRI Images. Journal of Medical and Biological Engineering, 43(3): 42.

Khojaste-Sarakhsi M, Haghighi S, Ghomi S, et al., 2022, Deep Learning for Alzheimer’s Disease Diagnosis: A Survey. Artificial Intelligence in Medicine, 130: 102332.

Frizzell T, Glashutter M, Liu C, et al., 2022, Artificial Intelligence in Brain MRI Analysis of Alzheimer’s Disease over the Past 12 Years: A Systematic Review. Ageing Research Reviews, 76: 101584.

Dhauria M, Mondal R, Deb S, et al., 2024, Blood-Based Biomarkers in Alzheimer’s Disease: Advancing Non-Invasive Diagnostics and Prognostics. International Journal of Molecular Sciences, 25(20): 10911.

Hampel H, Buerger K, Teipel S, 2020, Blood Biomarkers for Alzheimer’s Disease: Towards Clinical Implementation. Nature Reviews Neurology, 16(11): 673–690.

Shinohara R, Ye W, Salat D, et al., 2019, Data Processing and Harmonization for Multi-Site Neuroimaging Studies in Alzheimer’s Disease. NeuroImage, 199: 562–579.

Wang Y, Zhang Y, Li X, et al., 2023, Deep Learning-Based Plasma Biomarker Screening for Early Alzheimer’s Disease. Computational and Structural Biotechnology Journal, 21: 3825–3834.

Zhou Y, Wang X, Chen T, et al., 2022, Preprocessing Strategies for Plasma Proteomics Data in Alzheimer’s Disease Research. Journal of Proteomics, 263: 104532.

Qiu S, Miller M, Joshi P, et al., 2023, Multimodal Deep Learning for Alzheimer’s Disease Dementia Assessment. Nature Communications, 14(1): 4337.

Zhang D, Shen D, Suk H, et al., 2022, Deep Joint Learning Diagnosis of Alzheimer’s Disease Based on Multimodal Feature Fusion. Neurocomputing, 473: 140–151.

Huang H, Wang J, Li X, et al., 2021, Multimodal Representation Learning for Alzheimer’s Disease Diagnosis. Computer Science, 48(10): 1–9.

Singh A, Srivastava S, Khare S, 2022, Multimodal Data Fusion in Alzheimer’s Disease Diagnosis: A Review. Journal of Neuroscience Methods, 373: 109385.

Chen C, Liu Y, Zhang Y, et al., 2022, Cross-Modal Attention Network for Multimodal Alzheimer’s Disease Diagnosis. IEEE Journal of Biomedical and Health Informatics, 26(9): 4408–4418.

Alzheimer’s Association, 2023, Alzheimer’s Disease Facts and Figures. Alzheimer’s & Dementia, 19(3): 1107–1182.

Kim J, Jeong M, Stiles W, et al., 2022, Neuroimaging Modalities in Alzheimer’s Disease: Diagnosis and Clinical Features. International Journal of Molecular Sciences, 23(11): 6079.

Srivastava S, Ahmad R, Khare S, 2021, Alzheimer’s Disease and Its Treatment by Different Approaches: A Review. European Journal of Medicinal Chemistry, 216: 113320.

Zhang Y, Li X, Yang L, et al., 2023, Challenges and Future Directions of Multimodal Fusion in Alzheimer’s Disease Diagnosis. Frontiers in Aging Neuroscience, 15: 1126789.

Wang L, Chen Y, Zhou H, et al., 2022, Clinical Translation of Deep Learning Models for Alzheimer’s Disease: Current Status and Future Perspectives. Translational Neurodegeneration, 11(1): 52.